Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis
Niklas Bobrovitz, Rahul K. Arora, Christian Cao, et al.
PLoS ONE (2021) Vol. 16, Iss. 6, pp. e0252617-e0252617
Open Access | Times Cited: 239

Showing 1-25 of 239 citing articles:

Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies
Isabel Bergeri, Mairead Whelan, Harriet Ware, et al.
PLoS Medicine (2022) Vol. 19, Iss. 11, pp. e1004107-e1004107
Open Access | Times Cited: 216
Antibody Responses in COVID-19: A Review
Mateo Chvatal-Medina, Yorjagis Mendez-Cortina, Pablo Javier Patiño Grajales, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 137
SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021
Hannah C. Lewis, Harriet Ware, Mairead Whelan, et al.
BMJ Global Health (2022) Vol. 7, Iss. 8, pp. e008793-e008793
Open Access | Times Cited: 126
Reconciling estimates of global spread and infection fatality rates of COVID‐19: An overview of systematic evaluations
John P. A. Ioannidis
European Journal of Clinical Investigation (2021) Vol. 51, Iss. 5
Open Access | Times Cited: 124
The end of the COVID‐19 pandemic
John P. A. Ioannidis
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 6
Open Access | Times Cited: 72
Development of Prompt Templates for Large Language Model–Driven Screening in Systematic Reviews
Christian Cao, Jason Sang, Rohit Arora, et al.
Annals of Internal Medicine (2025)
Closed Access | Times Cited: 3
Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study
Fabrice Carrat, Xavier de Lamballerie, Delphine Rahib, et al.
International Journal of Epidemiology (2021) Vol. 50, Iss. 5, pp. 1458-1472
Open Access | Times Cited: 80
COVID-19 vaccine strategies must focus on severe disease and global equity
Peter McIntyre, Rakesh Aggarwal, Ilesh Jani, et al.
The Lancet (2021) Vol. 399, Iss. 10322, pp. 406-410
Open Access | Times Cited: 78
Update on SARS-CoV-2 seroprevalence: regional and worldwide
Ali Rostami, Mahdi Sepidarkish, Aylar Fazlzadeh, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 12, pp. 1762-1771
Open Access | Times Cited: 70
SARS-CoV-2 seroprevalence in children worldwide: a systematic review and meta-analysis
Reza Naeimi, Mahdi Sepidarkish, Abolfazl Mollalo, et al.
EClinicalMedicine (2022) Vol. 56, pp. 101786-101786
Open Access | Times Cited: 54
Estimating typhoid incidence from community-based serosurveys: a multicohort study
Kristen Aiemjoy, Jessica C. Seidman, Senjuti Saha, et al.
The Lancet Microbe (2022) Vol. 3, Iss. 8, pp. e578-e587
Open Access | Times Cited: 41
Silent battles: immune responses in asymptomatic SARS-CoV-2 infection
Nina Le Bert, Taraz Samandari
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 2, pp. 159-170
Closed Access | Times Cited: 9
The omicron variant of SARS-CoV-2 drove broadly increased seroprevalence in a public university setting
Ching‐Wen Hou, Stacy Williams, Guillermo Trivino-Soto, et al.
PLOS Global Public Health (2025) Vol. 5, Iss. 1, pp. e0003893-e0003893
Open Access | Times Cited: 1
Adapting Serosurveys for the SARS-CoV-2 Vaccine Era
Nathan Duarte, Mercedes Yanes‐Lane, Rahul K. Arora, et al.
Open Forum Infectious Diseases (2021) Vol. 9, Iss. 2
Open Access | Times Cited: 49
COVID‐19 vaccination in children and university students
John P. A. Ioannidis
European Journal of Clinical Investigation (2021) Vol. 51, Iss. 11
Open Access | Times Cited: 47
Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in 2020
Houssein H. Ayoub, Ghina R. Mumtaz, Shaheen Seedat, et al.
Global Epidemiology (2021) Vol. 3, pp. 100068-100068
Open Access | Times Cited: 43
Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico
Ana Basto‐Abreu, Martha Carnalla, Leticia Torres‐Ibarra, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 35
El impacto de la pandemia de COVID-19 sobre la salud. Informe SESPAS 2022
Alberto M. Torres‐Cantero, Eva Elisa Álvarez León, Inés Morán‐Sánchez, et al.
Gaceta Sanitaria (2022) Vol. 36, pp. S4-S12
Open Access | Times Cited: 29
Prompting is all you need: LLMs for systematic review screening
Christian Cao, Jason Sang, Rohit Arora, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Incidence and risk factors of COVID-19-like symptoms in the French general population during the lockdown period: a multi-cohort study
Fabrice Carrat, Mathilde Touvier, Gianluca Severi, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 41
Global SARS-CoV-2 seroprevalence: a systematic review and meta-analysis of standardized population-based studies from Jan 2020-May 2022
Isabel Bergeri, Mairead Whelan, Harriet Ware, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 41
Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis
Nuzrath Jahan, Adarsha Brahma, Muthusamy Santhosh Kumar, et al.
International Journal of Infectious Diseases (2021) Vol. 116, pp. 59-67
Open Access | Times Cited: 33
SARS-CoV-2 seroprevalence around the world: an updated systematic review and meta-analysis
Mobin Azami, Yousef Moradi, Asra Moradkhani, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 23
Seroprevalence of SARS-CoV-2 Antibodies in Africa: A Systematic Review and Meta-Analysis
Khalid Hajissa, Md Asiful Islam, Siti Asma Hassan, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 12, pp. 7257-7257
Open Access | Times Cited: 23
A real‐world evaluation of the implementation of NLP technology in abstract screening of a systematic review
Sara Perlman‐Arrow, Noel Loo, Niklas Bobrovitz, et al.
Research Synthesis Methods (2023) Vol. 14, Iss. 4, pp. 608-621
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top